2711019-49-5
2711019-49-5
Chemical Structure
GLP-1R agonist 1
- CAS No.: 2711019-49-5
- Formula:C32H29ClFN3O5
- Molecular Weight:590.04
IUPAC Name: 1a,10b-dihydro-6H-dibenzo[b,f]oxireno[2,3-d]azepine-1a-13C-6-carboxamide
InChIKey: DVQZQZUPAYGPQC-ICACTRECSA-N
SMILES: C[C@@]1(C2=C(C=C(C=C2)Cl)F)OC3=C(C4=CCN(CC(N(C5=C6)C[C@@H]7CCO7)=NC5=CC=C6C(O)=O)CC4)C=CC=C3O1
Biological Activity: GLP-1R agonist 1 is a fused imidazole GLP-1 receptor agonist with EC50 = 0.12 nM. GLP-1R agonist 1 exhibits weak inhibitory effect on hERG, with hERG potassium channel blockade IC50 = 22 μM. GLP-1R agonist 1 can be used for research on GLP-1-related diseases, such as diabetes[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
GLP-1R agonist 1 | GLP-1R agonist 1 is a fused imidazole GLP-1 receptor agonist with EC50 = 0.12 nM. GLP-1R agonist 1 exhibits weak inhibitory effect on hERG, with hERG potassium channel blockade IC50 = 22 μM. GLP-1R agonist 1 can be used for research on GLP-1-related diseases, such as diabetes. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
